Novocure, founded in Haifa, Israel in 2000, has evolved into a global oncology company dedicated to extending survival in aggressive forms of cancer through innovative therapy. With a focus on tumor treating fields, Novocure conducts ongoing clinical trials in various cancer types beyond glioblastoma and mesothelioma.
Committed to corporate social responsibility, Novocure collaborates with patients, caregivers, and advocacy partners to redefine living with cancer. The company's mission is centered on supporting independent organizations with shared goals to advance medical care and improve patient outcomes.
Generated from the website